Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis

NCT01396343

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama, Birmingham Birmingham, Alabama, United States
  • Pediatric MS Clinic, Children's Hospital, Loma Linda University San Bernardino, California, United States
  • UCSF Pediatric MS Center San Francisco, California, United States
  • Children's Hospital Colorado, University of Colorado School of Medicine Aurora, Colorado, United States
View all 17 locations
View Trial Details
Completed

Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis

NCT02461069

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Neurologisches Studienzentrum Dr. Schmidt/Dr. Neudecker/ Dr. Viehbahn/Dr. Kronenberger Bonn, Germany
  • Neurologische Gemeinschaftspraxis im Bienenkorbhaus Frankfurt am Main, Germany
  • Neurologische Univ.-Klinik Heidelberg, Germany
  • Klinik und Poliklinik für Neurologie, Universitätsklinikum Mainz Mainz, Germany
View Trial Details
Completed

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

NCT02398461

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Acorda Site #12 Long Beach, California, United States
  • Acorda Site #3 Sacramento, California, United States
  • Acorda Site #7 San Francisco, California, United States
  • Acorda Site #11 Aurora, Colorado, United States
View Trial Details
Completed

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

NCT00078338

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Barrow Neurology Clinics Phoenix, Arizona, United States
  • Northwest NeuroSpecialists Tucson, Arizona, United States
  • University of California, Davis Sacramento, California, United States
View all 80 locations
View Trial Details

Related conditions